Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ReShape Lifesciences (RSLS)

ReShape Lifesciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RSLS
DateTimeSourceHeadlineSymbolCompany
15/05/202421:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RSLSReShape Lifesciences Inc
15/05/202421:05GlobeNewswire Inc.ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
14/05/202413:31GlobeNewswire Inc.ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
01/04/202421:05GlobeNewswire Inc.ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
28/03/202412:31GlobeNewswire Inc.ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon SystemNASDAQ:RSLSReShape Lifesciences Inc
04/03/202413:31GlobeNewswire Inc.ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
26/02/202421:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
22/02/202413:31GlobeNewswire Inc.ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
24/01/202413:31GlobeNewswire Inc.ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
18/01/202421:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
16/01/202423:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RSLSReShape Lifesciences Inc
05/01/202421:14Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RSLSReShape Lifesciences Inc
20/12/202313:31GlobeNewswire Inc.ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership AlternativesNASDAQ:RSLSReShape Lifesciences Inc
12/12/202321:05GlobeNewswire Inc.ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
29/11/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
21/11/202313:06GlobeNewswire Inc.ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross ProceedsNASDAQ:RSLSReShape Lifesciences Inc
08/11/202321:05GlobeNewswire Inc.ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction PlanNASDAQ:RSLSReShape Lifesciences Inc
06/11/202313:31GlobeNewswire Inc.ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
13/10/202321:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
05/10/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
03/10/202314:23Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:RSLSReShape Lifesciences Inc
29/09/202317:30GlobeNewswire Inc.ReShape Lifesciences® Announces Pricing of $3.0 Million Public OfferingNASDAQ:RSLSReShape Lifesciences Inc
27/09/202322:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:RSLSReShape Lifesciences Inc
22/09/202321:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
22/09/202313:31GlobeNewswire Inc.ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVINASDAQ:RSLSReShape Lifesciences Inc
21/09/202313:31GlobeNewswire Inc.ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon SystemNASDAQ:RSLSReShape Lifesciences Inc
19/09/202313:31GlobeNewswire Inc.ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon SystemNASDAQ:RSLSReShape Lifesciences Inc
14/09/202313:31GlobeNewswire Inc.ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ DeviceNASDAQ:RSLSReShape Lifesciences Inc
25/08/202321:41Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:RSLSReShape Lifesciences Inc
07/08/202322:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RSLSReShape Lifesciences Inc
 Showing the most relevant articles for your search:NASDAQ:RSLS